We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$133B
AUM Growth
+$2.97B
(+2.3%)
Cap. Flow
+$494M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
28.35%
Holding
293
New
7
Increased
75
Reduced
134
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$635M |
| 2 |
United Airlines
UAL
|
+$620M |
| 3 |
Qualcomm
QCOM
|
+$401M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$302M |
| 5 |
Whirlpool
WHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$442M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$411M |
| 3 |
Adobe
ADBE
|
+$359M |
| 4 |
Texas Instruments
TXN
|
+$345M |
| 5 |
AT&T
T
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.69% |
| 2 | Healthcare | 23.27% |
| 3 | Industrials | 16.23% |
| 4 | Consumer Discretionary | 9.05% |
| 5 | Financials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
American Express
AXP
$230B
| $48.2M | 0.04% |
516,900
-7,800
| -1% | -$756K |
|
177
Charles River Laboratories
CRL
$12.8B
| $45.3M | 0.03% |
424,300
-1,600
| -0.4% | -$172K |
|
178
VF Corp
VFC
$5.89B
| $45.2M | 0.03% |
647,820
-156,645
| -19% | -$11.3M |
|
|
NUVA
179
DELISTED
NuVasive, Inc.
NUVA
| $43.6M | 0.03% |
835,100
-100
| -0% | -$5.07K |
|
180
Gildan
GIL
$10.6B
| $43.2M | 0.03% |
1,494,500
-214,800
| -13% | -$6.65M |
|
181
GSK
GSK
$106B
| $40.9M | 0.03% |
837,948
-20,080
| -2% | -$935K |
|
|
PRO
182
DELISTED
PROS Holdings
PRO
| $40.7M | 0.03% |
1,232,000
+622,913
| +102% | +$19.2M |
|
|
IMGN
183
DELISTED
Immunogen Inc
IMGN
| $40.2M | 0.03% |
3,823,300
| – | – |
|
184
Tyson Foods
TSN
$20.4B
| $38.3M | 0.03% |
523,600
-2,500
| -0.5% | -$191K |
|
185
Norfolk Southern
NSC
$75.1B
| $37.3M | 0.03% |
275,000
| – | – |
|
186
Stryker
SYK
$130B
| $36.3M | 0.03% |
225,500
-1,600
| -0.7% | -$258K |
|
187
T-Mobile US
TMUS
$190B
| $35.7M | 0.03% |
585,300
+243,300
| +71% | +$15.2M |
|
188
Standard BioTools
LAB
$314M
| $33.8M | 0.03% |
5,787,043
+11,900
| +0.2% | +$78.1K |
|
189
Altria Group
MO
$114B
| $32.9M | 0.02% |
528,204
+350,000
| +196% | +$23.2M |
|
|
HA
190
DELISTED
Hawaiian Holdings, Inc.
HA
| $32.2M | 0.02% |
831,500
+80,200
| +11% | +$2.99M |
|
|
ALTR
191
DELISTED
Altair Engineering Inc
ALTR
| $31.7M | 0.02% |
1,012,400
| – | – |
|
192
Old Dominion Freight Line
ODFL
$44.9B
| $29.8M | 0.02% |
609,000
-936,900
| -61% | -$44.4M |
|
193
Moody's
MCO
$82.7B
| $29.2M | 0.02% |
+181,000
| New | +$29.3M |
|
194
Accuray
ARAY
$34M
| $26.6M | 0.02% |
5,324,500
| – | – |
|
|
BBBY
195
DELISTED
Bed Bath & Beyond Inc
BBBY
| $25.8M | 0.02% |
1,228,850
-9,300
| -0.8% | -$205K |
|
196
MaxLinear
MXL
$6.8B
| $25.7M | 0.02% |
1,129,848
+279,948
| +33% | +$6.95M |
|
|
MB
197
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $25.1M | 0.02% |
646,377
| – | – |
|
198
NOV
NOV
$7B
| $24.2M | 0.02% |
656,666
-4,975
| -0.8% | -$182K |
|
|
SAVE
199
DELISTED
Spirit Airlines, Inc.
SAVE
| $23.9M | 0.02% |
633,821
-167,879
| -21% | -$7.04M |
|
|
AXON
200
Axon Enterprise
AXON
$46.4B
| $23.7M | 0.02% |
602,000
-58,000
| -9% | -$1.81M |
|
Similar funds
VAM
Primecap Management's Q1 2018 Portfolio in Review
As of Q1 2018, Primecap Management held 293 positions worth $133B, up 2.3% from $130B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.8%. Primecap Management opened 7 new positions and exited 7, leaving the 293-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2018 buy was Moody's: 181,000 shares worth $29.2M.
- Primecap Management added most to Bristol-Myers Squibb in Q1 2018, an estimated $635M increase.
- Primecap Management's biggest Q1 2018 reduction was NVIDIA, cutting an estimated $442M.
- Primecap Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $411M.
- Primecap Management's ten largest holdings make up 28% of its $133B portfolio in Q1 2018.
- Primecap Management opened 7 new positions and closed 7 in Q1 2018.
- Primecap Management's portfolio value rose 2.3% quarter-over-quarter to $133B.
Based on Primecap Management's 13F filing for Q1 2018, filed 14 May 2018.